The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Transepithelial transport and toxicity of PAMAM dendrimers: Implications for oral drug delivery
Open accessAbstract
This article summarizes efforts to evaluate poly(amido amine) (PAMAM) dendrimers as carriers for oral drug delivery. Specifically, the effect of PAMAM generation, surface charge and surface modification on toxicity, cellular uptake and transepithelial transport is discussed. Studies on Caco-2 monolayers, as models of intestinal epithelial barrier, show that by engineering surface chemistry of PAMAM dendrimers, it is possible to minimize toxicity while maximizing transepithelial transport. It has been demonstrated that PAMAM dendrimers are transported by a combination of paracellular and transcellular routes. Depending on surface chemistry, PAMAM dendrimers can open the tight junctions of epithelial barriers. This tight junction opening is in part mediated by internalization of the dendrimers. Transcellular transport of PAMAM dendrimers is mediated by a variety of endocytic mechanisms. Attachment or complexation of cytotoxic agents to PAMAM dendrimers enhances the transport of such drugs across epithelial barriers. A remaining challenge is the design and development of linker chemistries that are stable in the gastrointestinal tract (GIT) and the blood stream, but amenable to cleavage at the target site of action. Recent efforts have focused on the use of PAMAM dendrimers as penetration enhancers. Detailed in vivo oral bioavailability of PAMAM dendrimer – drug conjugates, as a function of physicochemical properties will further need to be assessed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Class of Polymers: Starburst-Dendritic Macromolecules
Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., & Smith, P. (1985) · Polymer Journal · doi:10.1295/polymj.17.117 · Cited by 3,904
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Tomalia, D. A., Naylor, A. M., & Goddard, W. A. (1990) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199001381 · Cited by 3,211
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Artursson, P., & Karlsson, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91647-u · Cited by 1,893
Malik, N., Wiwattanapatapee, R., Klopsch, R., Lorenz, K., Frey, H., Weener, J. W., Meijer, E. W., Paulus, W., & Duncan, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00246-1 · Cited by 1,227
Kukowska-Latallo, J. F., Bielinska, A. U., Johnson, J., Spindler, R., Tomalia, D. A., & Baker, J. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4897 · Cited by 1,006
The influence of surface modification on the cytotoxicity of PAMAM dendrimers
Jevprasesphant, R. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00623-3 · Cited by 726
Preliminary biological evaluation of polyamidoamine (PAMAM) StarburstTM dendrimers
Roberts, J. C., Bhalgat, M. K., & Zera, R. T. (1996) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199601)30:1<53::aid-jbm8>3.0.co;2-q · Cited by 589
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Ponchel, G. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00040-4 · Cited by 494
Intestinal Permeation Enhancers
Aungst, B. J. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200004)89:4<429::aid-jps1>3.0.co;2-j · Cited by 489
Kolhatkar, R. B., Kitchens, K. M., Swaan, P. W., & Ghandehari, H. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0603889 · Cited by 287
Self-citationD'Emanuele, A., Jevprasesphant, R., Penny, J., & Attwood, D. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.006 · Cited by 269
Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity
Jevprasesphant, R., Penny, J., Attwood, D., McKeown, N. B., & D'Emanuele, A. (2003) · Pharmaceutical Research · doi:10.1023/a:1026166729873 · Cited by 256
Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers
El-Sayed, M., Ginski, M., Rhodes, C., & Ghandehari, H. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00087-1 · Cited by 251
Self-citationWiwattanapatapee, R., Carreño-Gómez, B., Malik, N., & Duncan, R. (2000) · Pharmaceutical Research · doi:10.1023/a:1007587523543 · Cited by 234
Yiyun, C., Na, M., Tongwen, X., Rongqiang, F., Xueyuan, W., Xiaomin, W., & Longping, W. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20745 · Cited by 225
Cheng, Y., Qu, H., Ma, M., Xu, Z., Xu, P., Fang, Y., & Xu, T. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.12.035 · Cited by 206
In vitro evaluation of dendrimer prodrugs for oral drug delivery
Najlah, M., Freeman, S., Attwood, D., & D’Emanuele, A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.047 · Cited by 195
Ma, M., Cheng, Y., Xu, Z., Xu, P., Qu, H., Fang, Y., Xu, T., & Wen, L. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.07.015 · Cited by 190
Asthana, A., Chauhan, A. S., Diwan, P. V., & Jain, N. K. (2005) · AAPS PharmSciTech · doi:10.1208/pt060367 · Cited by 190
Nanomedicine: Clinical Applications of Polyethylene Glycol Conjugated Proteins and Drugs
Parveen, S., & Sahoo, S. K. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645100-00002 · Cited by 189
Novel Prodrugs of SN38 Using Multiarm Poly(ethylene glycol) Linkers
Zhao, H., Rubio, B., Sapra, P., Wu, D., Reddy, P., Sai, P., Martinez, A., Gao, Y., Lozanguiez, Y., Longley, C., et al. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700333s · Cited by 188
Endocytosis and Interaction of Poly (Amidoamine) Dendrimers with Caco-2 Cells
Kitchens, K. M., Foraker, A. B., Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9415-0 · Cited by 182
Self-citationTransepithelial and endothelial transport of poly (amidoamine) dendrimers
KITCHENS, K., ELSAYED, M., & GHANDEHARI, H. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.013 · Cited by 177
Self-citationKitchens, K. M., Kolhatkar, R. B., Swaan, P. W., Eddington, N. D., & Ghandehari, H. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9122-2 · Cited by 167
Self-citationSize and surface charge significantly influence the toxicity of silica and dendritic nanoparticles
Greish, K., Thiagarajan, G., Herd, H., Price, R., Bauer, H., Hubbard, D., Burckle, A., Sadekar, S., Yu, T., Anwar, A., et al. (2012) · Nanotoxicology · doi:10.3109/17435390.2011.604442 · Cited by 166
Self-citationEnhanced Oral Bioavailability of Doxorubicin in a Dendrimer Drug Delivery System
Ke, W., Zhao, Y., Huang, R., Jiang, C., & Pei, Y. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21155 · Cited by 165
Models for Assessing Drug Absorption and Metabolism
Borchardt, R. T., Smith, P. L., & Wilson, G. (1996) · Pharmaceutical biotechnology · doi:10.1007/978-1-4899-1863-5 · Cited by 157
Kitchens, K. M., Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700089s · Cited by 157
Self-citationTransport of dendrimer nanocarriers through epithelial cells via the transcellular route
Jevprasesphant, R., Penny, J. I., Attwood, D., & D’Emanuele, A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.022 · Cited by 156
Fox, M. E., Guillaudeu, S. J., Fréchet, J. M. J., Jerger, K., Macaraeg, N., & Szoka, F. C. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9001206 · Cited by 150
Oral uptake and translocation of a polylysine dendrimer with a lipid surface
Florence, A. T., Sakthivel, T., & Tóth, I. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00237-0 · Cited by 108
Probing the mechanism of transport and compartmentalisation of polyamines in mammalian cells
Cullis, P. M., Green, R. E., Merson‐Davies, L., & Travis, N. G. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(00)80019-8 · Cited by 103
Potential Oral Delivery of 7-Ethyl-10-Hydroxy-Camptothecin (SN-38) using Poly(amidoamine) Dendrimers
Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9572-9 · Cited by 100
Self-citationComparative Biodistribution of PAMAM Dendrimers and HPMA Copolymers in Ovarian-Tumor-Bearing Mice
Sadekar, S., Ray, A., Janat-Amsbury, M. M., Peterson, C. M., & Ghandehari, H. (2010) · Biomacromolecules · doi:10.1021/bm101046d · Cited by 96
Self-citationSweet, D., Kolhatkar, R. B., Ray, A., Swaan, P. W., & Ghandehari, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.022 · Cited by 93
Self-citationCarboxyl-Terminated PAMAM-SN38 Conjugates: Synthesis, Characterization, and in Vitro Evaluation
Vijayalakshmi, N., Ray, A., Malugin, A., & Ghandehari, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100094z · Cited by 66
Self-citationConjugation of Camptothecins to Poly‐(l‐Glutamic Acid)
Singer, J. W., de Vries, P. W., Bhatt, R., Tulinsky, J., KLEIN, P., Li, C., Milas, L., LEWIS, R. A., & Wallace, S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb07032.x · Cited by 66
Goldberg, D. S., Ghandehari, H., & Swaan, P. W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0153-3 · Cited by 65
Self-citationPermeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers
Pisal, D. S., Yellepeddi, V., Kumar, A., Kaushik, R. S., Hildreth, M. B., Guan, X., & Palakurthi, S. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.08.033 · Cited by 59
Illum, L. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00260-0 · Cited by 52
Thiagarajan, G., Ray, A., Malugin, A., & Ghandehari, H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0179-6 · Cited by 51
Self-citationRelaxivity of Nanoparticles for Magnetic Resonance Imaging
Sattler, K. (2010) · CRC Press eBooks · doi:10.1201/9781420075496-32 · Cited by 37
Transport of Surface Engineered Polyamidoamine (PAMAM) Dendrimers Across IPEC-J2 Cell Monolayers
Pisal, D. S., Yellepeddi, V., Kumar, A., & Palakurthi, S. (2008) · Drug Delivery · doi:10.1080/10717540802321826 · Cited by 24
Lin, Y.-L., Khanafer, K., & ElSayed, M. E. H. (2010) · Nanoscale · doi:10.1039/b9nr00407f · Cited by 23
Functionalized Dendrimers as Nanoscale Drug Carriers
Kolhatkar, R. B., Sweet, D., & Ghandehari, H. (2008) · Fundamental biomedical technologies · doi:10.1007/978-0-387-76554-9_7 · Cited by 13
Self-citation
Cited by
Dendrimer as nanocarrier for drug delivery
Kesharwani, P., Jain, K., & Jain, N. K. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2013.07.005 · Cited by 1,146
Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review
Hossen, S., Hossain, M. K., Basher, M. K., Mia, M. N. H., Rahman, M. T., & Uddin, M. J. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2018.06.005 · Cited by 998
Polymeric Conjugates for Drug Delivery
Larson, N., & Ghandehari, H. (2012) · Chemistry of Materials · doi:10.1021/cm2031569 · Cited by 580
Self-citationRen, X., Feng, Y., Guo, J., Wang, H., Li, Q., Yang, J., Hao, X., Lv, J., Ma, N., & Li, W. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00483c · Cited by 573
Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications
Kannan, R. M., Nance, E., Kannan, S., & Tomalia, D. A. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12280 · Cited by 542
Metadata
- Authors
- Sadekar, S., & Ghandehari, H.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 64
- Issue
- 6
- Pages
- 571-588
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2038156568
- Cited by
- 311
- References
- 49
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.